Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

438 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

NCT07284459

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Instituto de Especialidades de la Salud Rosario - Clínica del Tórax Rosario, Santa Fe Province, Argentina
  • Centro de Investigaciones Médicas Tucumán - PPDS San Miguel de Tucumán, Tucumán Province, Argentina
  • IPR-Investigaciones en Patologías Respiratorias San Miguel de Tucumán, Tucumán Province, Argentina
  • Centro Modelo de Cardiología-Laprida 554 San Miguel de Tucumán, Tucumán Province, Argentina
View all 65 locations
View Trial Details
Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

NCT06968845

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Paradigm Clinical Research Centers, LLC San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 36 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

NCT01915511

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, +6 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • University of Southern California Los Angeles, California, United States
View all 47 locations
View Trial Details
Recruiting

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

NCT07194382

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Nepean Lung and Sleep Kingswood, New South Wales, Australia
  • Dynamic Drug Advancement Ajax, Ontario, Canada
  • CIC Mauricie Trois-Rivières, Quebec, Canada
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 24 locations
View Trial Details
Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06967805

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • WISPer Site in Birmingham, AL Birmingham, Alabama, United States
  • WISPer site in Phoenix, AZ Phoenix, Arizona, United States
  • WISPer Site in Los Angeles, CA Los Angeles, California, United States
  • WISPer site in Newport Beach, CA Newport Beach, California, United States
View all 71 locations
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 68 locations
View Trial Details

Related conditions